Browsing by Author "Verdejo, Hugo"

Now showing items 1-3 of 3

    • Galectina-3: experiencia en pacientes chilenos con diagnóstico de insuficiencia cardíaca descompensada 
      Rossel Mariángel, Víctor; Díaz Toro, Felipe; Verdejo, Hugo; Concepción, Roberto; Sepúlveda, Luis; Castro, Pablo; Vukasovic, José Luis; Bernales, Angie; Bernales, Angie (Sociedad Medica de Santiago, 2017)
      Background: Galectin-3 (Gal-3) is a mediator of myocardial fibrosis involved in cardiac remodeling and a potential new prognosis marker in heart failure (HF). Aim: To measure Gal-3 at the moment of discharge in patients ...
    • Incidencia e importancia pronóstica del deterioro de la función renal en pacientes hospitalizados con ... 
      Castro, Pablo; Verdejo, Hugo; Altamirano, Rodrigo; Downey, Patricio; Vukasovic, José Luis; Sepúlveda Jaqui, Luis; Lanas, Fernando; Bilbao, Paola; Pacheco, Ricardo; Rossel Mariángel, Víctor (Sociedad Médica de Santiago, 2013)
      Background: Acute deterioration of kidney function among patients admitted to the hospital for cardiac failure is associated with an increased mortality. Aim: To investigate the association between deterioration of kidney ...
    • Metabolismo energético del corazón y sus proyecciones en el tratamiento de la insuficiencia cardíaca 
      Castro, Pablo; Gabrielli, Luigi A.; Verdejo, Hugo; Greig, Douglas; Mellado, Rose Marie; Concepción, Roberto; Sepúlveda Morales, Luis; Vukasovic Ramírez, José Luis; García Nannig, Lorena; Pizarro, Marcela; Pivet, Deisy; Carrillo, Constanza; Tapia, Fabiola; Navarro, Mario; Troncoso, Rodrigo; Baraona, Fernando; Llevaneras, Silvana; Hernández, Claudia; Godoy, Iván; Jalil Milad, Jorge; Quintana, Juan Carlos; Orellana, Pilar; Chiong Lay, Mario; Lavandero González, Sergio (SOC MEDICA SANTIAGO, 2010-08)
      It is unknown why heart failure progresses even when patients are treated with the best therapy available. Evidences suggest that heart failure progression is due to loss of neurohumoral blockade in advanced stages of the ...